Opinion: If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it
Most visits to the memory center where I care for individuals living with Alzheimer’s disease end in disappointment.
“Are there any new treatments, Dr. Karlawish?” patients or family members hopefully ask.
